Implementation Report. Within 150 days after the Effective Date, Ensign Group shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have; 2. the names and positions of the members of the Compliance Committee required by Section III.A; 3. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3; 4. a copy of Ensign Group’s Code of Conduct required by Section III.B.1; 5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request); 6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request); 7. the following information regarding each type of training required by Section III.C: a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions; b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request. 8. a description of the Disclosure Program required by Section III.E; 9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group; 10. a description of the process by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons; 11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims; 12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 2 contracts
Sources: Corporate Integrity Agreement (Ensign Group, Inc), Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group KDMC shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. the names, addresses, phone numbers, and position descriptions of the Physician Executive(s) required by Section III.A.6, and a summary of other job responsibilities that each Physician Executive may have;
5. the name, address, phone number, and position description of the Medical Director of the Cardiac Catheterization Laboratory required by Section III.A.7, and a summary of other job responsibilities the Medical Director may have;
6. a copy of Ensign GroupKDMC’s Code of Conduct required by Section III.B.1;
57. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be made available to OIG upon request);
68. a summary of all Policies and Procedures required by Section III.B III.B.2 (copies of the Policies and Procedures shall be made available to OIG upon request);
79. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;; and
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
810. a description of (a) the Focus Arrangements Tracking System required by Section III.F.1.a, (b) the internal review and approval process required by Section III.F.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.F.1; 11. a description of the Disclosure Program required by Section III.EIII.G;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
10. a description of the process by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 2 contracts
Sources: Corporate Integrity Agreement, Corporate Integrity Agreement
Implementation Report. Within 150 days after the Effective Date, Ensign Group Halifax shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors Commissioners compliance obligations described in Section III.A.3;
4. a copy of Ensign GroupHalifax’s Code of Conduct required by Section III.B.1;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be made available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy ; and
c. with respect to active medical staff members, the number and percentage who completed the training, the type of all training materials and the documentation supporting this information shall be made available date received, and a description of Halifax’s efforts to OIG upon requestencourage medical staff members to complete the training.
8. a description of: (a) the Focus Arrangements Tracking System required by Section III.D.1.a; (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1; 9. a description of the Disclosure Program required by Section III.EIII.F;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
10. a description of the process by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 2 contracts
Sources: Corporate Integrity Agreement, Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group Genova shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, business address, business phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of Ensign Group’s Code of Conduct the written process for Certifying Employees to follow in order to complete the certification required by Section III.B.1III.A.4;
5. the number name, business address, business phone number, and position description of individuals required to complete the Code of Conduct certification Chief Clinical Officer required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request)III.A.5 ;
6. a summary list of all the Policies and Procedures required by Section III.B (copies and a copy of the Policies and Procedures shall be made available to OIG upon request)all current order and/or requisition forms in use by Genova;
7. the following information regarding each type Training Plan required by Section III.C.1 and a description of the Board training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessionsthe training, and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of the Disclosure Program required by Section III.E;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupGenova that includes a summary of all current and prior engagements between Genova and the IRO;
9. a description of the risk assessment and internal review process required by Section III.E; 10. a description of the process Disclosure Program required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
III.F; 11. a list description of all of Ensign Group’s locations (including locations the Ineligible Persons screening and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claimsremoval process required by Section III.G;
12. a description copy of Ensign GroupGenova’s corporate structurepolicies and procedures regarding the identification, including identification quantification and repayment of any parent and sister companies, subsidiaries, and their respective lines of business; andOverpayments required by Section III.I;
Appears in 2 contracts
Sources: Corporate Integrity Agreement, Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group Progenity shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, business address, business phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of Ensign Group’s Code of Conduct the written process for Certifying Employees to follow in order to complete the certification required by Section III.B.1III.A.4;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary list of all Policies and Procedures required by Section III.B (copies III.B;
6. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of Board training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessionsthe training, and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of (a) the Disclosure Program Focus Arrangements Tracking System required by Section III.EIII.D.1.a, (b) the internal review and approval process required by Section III.D.1.g; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupProgenity or that it does not have a prohibited relationship with Progenity as set forth in Section III.E.4, that includes a summary of all current and prior engagements or relationships between Progenity and the IRO, as applicable;
9. a description of the risk assessment and internal review process required by Section III.F; 10. a description of the process Disclosure Program required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
III.G; 11. a list description of all of Ensign Group’s locations (including locations the Ineligible Persons screening and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claimsremoval process required by Section III.H;
12. a description copy of Ensign GroupProgenity’s corporate structurepolicies and procedures regarding the identification, including identification quantification and repayment of any parent and sister companies, subsidiaries, and their respective lines of business; andOverpayments required by Section III.J;
Appears in 2 contracts
Sources: Corporate Integrity Agreement (Progenity, Inc.), Corporate Integrity Agreement (Progenity, Inc.)
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group Odyssey Hospice shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. a copy of Ensign GroupParent’s Code of Business Ethics and Conduct required by Section III.B.1;
54. the number of individuals required to complete the Code of Business Ethics and Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
65. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);): Odyssey Corporate Integrity Agreement
76. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of the Disclosure Program required by Section III.E;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group Odyssey Hospice or Parent and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupOdyssey Hospice and Parent;
109. a description of the process by which Ensign Group Odyssey Hospice fulfills the requirements of Section III.F regarding Ineligible Persons;
1110. a list of all of Ensign GroupOdyssey Hospice’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group Odyssey Hospice currently submits claims;
1211. a description of Ensign GroupOdyssey Hospice’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; andand Odyssey Corporate Integrity Agreement
12. the certifications required by Section V.C.
Appears in 1 contract
Sources: Corporate Integrity Agreement (Gentiva Health Services Inc)
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group AtriCure, Inc. shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board Committee of Directors who are responsible for satisfying the Board of Directors compliance obligations described referenced in Section III.A.3III.A.3 4. the names and positions of the Certifying Employees required by Section III.A.4;
45. a copy of Ensign GroupAtriCure, Inc.’s Code of Conduct required by Section III.B.1;
56. a copy of all Policies and Procedures required by Section III.B.2;
7. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG OIG, upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
78. the following information regarding each type of training required by Section III.C:
a. a description of such the initial and annual training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;; and CORPORATE INTEGRITY AGREEMENT ATRICURE, INC.
b. the number of individuals required to be trainedcomplete the initial and annual training, the percentage of individuals who actually trainedcompleted the initial and annual training, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG OIG, upon request.
89. a description of the Disclosure Program required by Section III.E;
910. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; and (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group AtriCure, Inc. and the IRO; and (e) ;
11. a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupAtriCure, Inc.;
1012. a description of the process by which Ensign Group AtriCure, Inc. fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group DaVita shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Chief Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Chief Compliance Officer may have;
2. the names and positions of the members of the Management Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. a copy of Ensign GroupDaVita Dialysis’s Code of Conduct required by Section III.B.1;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be made available to OIG upon request);
6. a summary copies of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request)III.B.2;
7. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
. DaVita HealthCare Partners Inc. Corporate Integrity Agreement 8. a description of of: (a) the Disclosure Program Selection Process and Selection Criteria required by Section III.E;
9. the following information regarding the IRO(s): (a) identity, address, and phone numberIII.D.1; (b) a copy of the engagement letterValuation Methodologies required by Section III.D.2; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIAFocus Arrangements Tracking System required by Section III.D.3.a; (d) a summary the internal review and description of any and all current and prior engagements and agreements between Ensign Group and the IROapproval process required by Section III.D.3.f; and (e) a certification from the IRO regarding its professional independence tracking and objectivity with respect to Ensign Groupmonitoring procedures and other Focus Arrangements Procedures required by Section III.D.3;
10. a description of the process by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement (Davita Healthcare Partners Inc.)
Implementation Report. Within 150 days after the Effective Date, Ensign Group WBH shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;III.A;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of Ensign Group’s Code of Conduct required by Section III.B.1;the written process for Certifying Employees to follow;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary list of all Policies and Procedures required by Section III.B (copies III.B;
6. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessionsthe training, and a schedule of when the training sessions;was provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of (a) the Disclosure Program Focus Arrangements Tracking System required by Section III.E;III.D.1.a, (b) the internal review and approval process required by Section III.D.1.g; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
10. a description of the process by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; andand
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group RMS shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, business address, business phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of Ensign Group’s Code the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;
5. a list of Conduct the Policies and Procedures required by Section III.B.1;
56. the number of individuals required to complete the Code of Conduct certification Training Plan required by Section III.B.1, the percentage of individuals who have completed such certification, III.C.1 and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of Board training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of the Disclosure Program risk assessment and internal review process required by Section III.EIII.D;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
RMS that includes a summary of all current and prior engagements between RMS and the IRO; 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by which Ensign Group fulfills Section III.G; 11. a description of the requirements of FFMP required by Section III.F regarding Ineligible PersonsIII.K;
1112. a description of the policies, procedures, and systems implemented pursuant to the Requirements Relating to Certain Promotional and Non-Promotional Activities outlined in Section III.L; 13. a certification from the Compliance Officer that information regarding Payments has been posted on RMS’s website as required by Section III.M;
14. a list of all of Ensign GroupRMS’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; and the corresponding phone numbers and fax numbers; each location’s locations’ Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims) if any;
1215. a description of Ensign GroupRMS’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
16. the certifications required by Section V.C.
Appears in 1 contract
Sources: Corporate Integrity Agreement (Ra Medical Systems, Inc.)
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group UHS shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Audit Committee of the Board of Directors compliance obligations described in Section III.A.3III.A;
4. a copy description of Ensign Group’s Code the Quality of Conduct Care Review Program required by Section III.B.1III.A.2;
5. a description of the number Dashboard required by Section III.A.2;
6. the names and positions of individuals the Certifying Employees required to complete by Section III.A.4 and a copy of the Code of Conduct written process for completing the certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request)III.A.4;
67. a summary list of all Policies and Procedures required by Section III.B (copies III.B;
8. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessionsthe training, and a schedule of when the training sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of the Disclosure Program required by Section III.Ewas provided);
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupUHS that includes a summary of all current and prior engagements between UHS and the IRO;
10. a description of the risk assessment and internal review process required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses)III.F; the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a 11.a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; andthe Disclosure Program required by Section III.G;
Appears in 1 contract
Sources: Corporate Integrity Agreement (Universal Health Services Inc)
Implementation Report. Within 150 days after the Effective Date, Ensign Group Avanir shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;III.A.2;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of Ensign Group’s Code of Conduct required the written process to be followed by Section III.B.1;
5. Certifying Employees in connection with completing the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);III.A.4;
65. a summary list of all the Policies and Procedures required by Section III.B (copies III.B.3;
6. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training and a schedule of when the training sessions;was provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of the Disclosure Program risk assessment and mitigation plan process required by Section III.E;III.D;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with with respect to Ensign Group;
Avanir that includes a summary of all current and prior engagements between ▇▇▇▇▇▇ and the IRO; 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; andIII.G;
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group ▇▇▇▇▇▇▇▇▇▇ Regional shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. a copy of Ensign Group▇▇▇▇▇▇▇▇▇▇ Regional’s Code of Conduct required by Section III.B.1;; ▇▇▇▇▇▇▇▇▇▇ Regional Medical Center Corporate Integrity Agreement
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of the Disclosure Program required by Section III.E;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group ▇▇▇▇▇▇▇▇▇▇ Regional and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group▇▇▇▇▇▇▇▇▇▇ Regional;
10. a description of the process by which Ensign Group ▇▇▇▇▇▇▇▇▇▇ Regional fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group▇▇▇▇▇▇▇▇▇▇ Regional’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name ▇▇▇▇▇▇▇▇▇▇ Regional Medical Center Corporate Integrity Agreement and address of each Medicare and state Medicaid program contractor to which Ensign Group ▇▇▇▇▇▇▇▇▇▇ Regional currently submits claims;
12. a description of Ensign Group▇▇▇▇▇▇▇▇▇▇ Regional’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 days after the Effective Date, Ensign Group Spectranetics shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Chief Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Chief Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the members of the Spectranetics’ Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described referenced in Section III.A.3;
4. a copy of Ensign Group’s Spectranetics’ Code of Conduct required by Section III.B.1;
5. a copy of all Policies and Procedures required by Section III.B.2;
6. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG OIG, upon request);
7. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;; and
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. Spectranetics Corporate Integrity Agreement A copy of all training materials and the documentation supporting this information shall be made available to OIG OIG, upon request.
8. a description of the Disclosure Program required by Section III.E;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; and (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group Spectranetics and the IRO; and (e) ;
10. a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupSpectranetics;
1011. a description of the process by which Ensign Group Spectranetics fulfills the requirements of Section III.F regarding Ineligible Persons;
1112. the name, title, and responsibilities of any person who is determined to be an Ineligible Person under Section III.F; the actions taken in response to the screening and removal obligations set forth in Section III.F;
13. a list of all of Ensign Group’s Spectranetics’ locations (including locations and mailing addresses)) at which it performs Promotional and Product Services Related Functions, Reporting Related Functions, and Clinical Investigation Related Functions; the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program Federal health care provider number and/or supplier number(s) (if applicable); and the name and address of each Medicare and state Medicaid Federal health care program contractor to which Ensign Group Spectranetics currently submits claimsclaims (if applicable);
1214. a description of Ensign Group’s Spectranetics’ corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group USPh shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. a copy of Ensign GroupUSPh’s Code of Conduct required by Section III.B.1;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B III.B.2 (copies of the Policies and Procedures shall be made available to OIG upon request);
76. the following information regarding each type Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessionsthe training, and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of the Disclosure Program required by Section III.E;
97. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group USPh and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupUSPh;
108. a description of the risk assessment and mitigation process required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses)III.E; the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
129. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; andthe Disclosure Program required by Section III.F;
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group King shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:: Corporate Integrity Agreement King Pharmaceuticals, Inc.
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions a copy of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in King’s Code required by Section III.A.3III.B.1;
4. a copy of Ensign Group’s Code of Conduct all Policies and Procedures required by Section III.B.1III.B.2;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG OIG, upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, sessions and a schedule of training sessions;; and
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials used in the training required by Section III.C and the documentation supporting this information shall be made available to OIG OIG, upon request.
87. a description of the Disclosure Program required by Section III.E;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group King and the IRO; and (ed) the proposed start and completion dates of the Engagement; Corporate Integrity Agreement King Pharmaceuticals, Inc.
9. a certification from the IRO regarding its professional independence and and/or objectivity with respect to Ensign GroupKing;
10. a description of the process by which Ensign Group King fulfills the requirements of Section III.F regarding Ineligible Persons;
11. the name, title, and responsibilities of any person who is determined to be an Ineligible Person under Section III.F; the actions taken in response to the screening and removal obligations set forth in Section III.F; and the actions taken to identify, quantify, and repay any overpayments to Federal Health Care Programs relating to items or services furnished, ordered or prescribed by an Ineligible Person;
12. a list of all of Ensign GroupKing’s locations (including locations and mailing addresses)) as required by Section IV; the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program Federal Health Care Program provider number and/or or supplier number(s) (if any); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group King currently submits claimsclaims (if any);
1213. a description of Ensign GroupKing’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and;
Appears in 1 contract
Sources: Corporate Integrity Agreement (King Pharmaceuticals Inc)
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group 21st Century shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Chief Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Chief Compliance Officer may have;
2. the names, addresses, phone numbers, and position descriptions of the Regional Compliance Officers required by Section III.A.2,
3. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.3;
34. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3III.A.4;
45. the names and positions of the Certifying Employees required by Section III.A.5.
6. a copy of Ensign Group21st Century’s Code of Conduct required by Section III.B.1;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
67. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
78. the following information regarding each type Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training; and a schedule of when the training sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of the Disclosure Program required by Section III.Ewas provided);
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group 21st Century and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group21st Century;
10. a description of the risk assessment and internal review process required by which Ensign Group fulfills Section III.E;
11. a description of the Disclosure Program required by Section III.F;
12. a certification that 21st Century has implemented screening requirements of described in Section III.F III.G regarding Ineligible Persons, or a description of why 21st Century cannot provide such a certification;
1113. a copy of 21st Century’s policies and procedures regarding the identification, quantification and repayment of Overpayments required by Section III.I;
14. a list of all of Ensign Group21st Century’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; , each location’s Medicare and state Medicaid TRICARE program provider number number(s) and/or supplier number(s); , and the name and address of each Medicare and state Medicaid TRICARE program contractor to which Ensign Group 21st Century currently submits claims;
1215. a description of Ensign Group21st Century’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
16. the certifications required by Section V.C.
Appears in 1 contract
Sources: Corporate Integrity Agreement (21st Century Oncology Holdings, Inc.)
Implementation Report. Within 150 days after the Effective Date, Ensign Group Par shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described referenced in Section III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4; Par Corporate Integrity Agreement
5. a copy of Ensign GroupPar’s Code of Conduct required by Section III.B.1;
56. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG OIG, upon request);
67. a summary of all Policies and Procedures required by Section III.B III.B.2 (copies a copy of the such Policies and Procedures shall be made available to OIG upon request);
78. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;; and
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. .. A copy of all training materials and the documentation supporting this information shall be made available to OIG OIG, upon request.
8. a description of the Disclosure Program required by Section III.E;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; and (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIAA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group Par and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
Par; 10. a description of the process Disclosure Program required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible PersonsIII.F;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group ▇▇▇▇▇▇ shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors Managers compliance obligations described in Section III.A.3;
4. a copy the names and positions of Ensign Group’s Code of Conduct the Certifying Employees required by Section III.B.1III.A.4;
5. a list of the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies III.B;
6. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type Board of Managers training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessionsthe training, and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of the Disclosure Program required by Section III.E;
97. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group▇▇▇▇▇▇;
8. a description of the risk assessment and internal review process required by Section III.E; 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible PersonsIII.G;
11. a copy of ▇▇▇▇▇▇’▇ policies and procedures regarding the identification, quantification and repayment of Overpayments required by Section III.I;
12. a list of all of Ensign Group’s ▇▇▇▇▇▇’▇ locations (including locations and mailing addresses); , the corresponding name under which each location is doing business; , and the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid Federal health care program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
1213. a description of Ensign Group’s ▇▇▇▇▇▇’▇ corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group UMHS shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Chief Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Chief Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors Curators compliance obligations described in Section III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4;
5. a copy of Ensign GroupUMHS’s Code of Conduct required by Section III.B.1;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B III.B.2 (copies of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type Training Plan required by Section III.C.1 and a description of the Board of Curators training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessionsthe training, and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of the Disclosure Program required by Section III.E;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group UMHS and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupUMHS;
9. a description of the risk assessment and internal review process required by Section III.E; 10. a description of the process Disclosure Program required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible PersonsIII.F;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 days after the Effective Date, Ensign Group CVS Health shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Chief Compliance Officer, the Compliance Officer for IPS Operations, and the Arrangements Officer for IPS Operations required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer, the Compliance Officer for IPS Operations Officer, and the Arrangements Officer for IPS Operations may have;
2. the names and positions of the members of the IPS Operations Compliance Committee and the Compliance Committee required by Section III.AIII.A.3;
3. the names and positions of the Board members who are members of the Board of Directors Committee who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3III.A.4;
4. a copy the names and positions of Ensign Group’s Code of Conduct the Certifying Employees required by Section III.B.1III.A.5;
5. the number a copy of individuals required to complete the CVS Health’s Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request)Conduct;
6. a summary of all Policies and Procedures required by Section III.B III.B.2 (copies of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessionsthe training, and a schedule of when the training sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
was provided); 8. a description of (a) the Disclosure Program Focus Arrangements Database required by Section III.D.1.a, (b) the internal review and approval process required by Section III.D.1.g; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1; 9. a description of the Accurate Prescription Drug Labeling and Dispensing Systems and Procedures required by Section III.E;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
10. a description of the process by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 days after the Effective Date, Ensign Group Merit shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include::
1. the name, business address, business phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;;
2. the names and positions of the members of the Compliance Committee required by Section III.A;III.A.2;
3. the names of the Audit Committee members who are responsible for satisfying the Board compliance obligations described in Section III.A.3;
4. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in Certifying Employees required by Section III.A.3;
4. III.A.4 and a copy of Ensign Group’s Code of Conduct required by Section III.B.1;
5. the number of individuals required written process for Certifying Employees to follow in order to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);III.A.4;
65. a summary list of all the Policies and Procedures required by Section III.B (copies III.B.1;
6. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training and a schedule of when the training sessions;was provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of the Disclosure Program risk assessment and internal review process required by Section III.EIII.D;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;Merit that includes a summary of all current and prior engagements between Merit and the IRO;
9. a description of the Disclosure Program required by Section III.F;
10. a description of the Ineligible Persons screening and removal process required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible PersonsIII.G;
11. a list description of all of Ensign Group’s locations (including locations policies, procedures, and mailing addresses)systems implemented pursuant to the Requirements Relating to Certain Promotional Activities outlined in Section III.K; the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of businessthe FFMP required by Section III.L; and
Appears in 1 contract
Sources: Corporate Integrity Agreement (Merit Medical Systems Inc)
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group ▇▇▇▇▇▇ shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.2;
3. the names and positions of the Certifying Employees required by Section III.A.3;
4. a copy of Ensign Group▇▇▇▇▇▇’s Code of Conduct required by Section III.B.1;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
76. the following information regarding each type Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessionsthe training, and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of (a) the Disclosure Program Focus Arrangements Tracking System required by Section III.EIII.D.1.a, (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group Balboa and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupBalboa;
9. a description of the risk assessment and internal review process required by Section III.F; 10. a description of the process Disclosure Program required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible PersonsIII.G;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 days after the Effective Date, Ensign Group Baptist shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. a copy of Ensign GroupBaptist’s Code of Conduct required by Section III.B.1;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be made available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;; and,
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of the Disclosure Program required by Section III.E;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group Baptist and the IRO; and and, (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
Baptist; 10. a description of the process by which Ensign Group Baptist fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign GroupBaptist’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number number(s) and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group Baptist currently submits claims;
12. a description of Ensign GroupBaptist’s corporate structure, including identification of any parent structure and sister companies, subsidiaries, and their its respective lines of business; and,
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group ▇▇▇▇▇▇▇▇ shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. a copy of Ensign Group’s ▇▇▇▇▇▇▇▇’▇ Code of Conduct required by Section III.B.1;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;; and
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1; 9. a description of the Disclosure Program required by Section III.EIII.F;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
10. a description of the process by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 180 days after the Effective Date, Ensign Group Allergan shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Chief Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Chief Compliance Officer may have;
2. the names and positions of the members of the U.S. Compliance Committee required by Section III.AIII.A.2;
3. the names of the members of the full Board of Directors and any Committee of the Board with responsibility for compliance as referenced in Section III.A.3;
4. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in Certifying Employees required by Section III.A.3III.A.4;
45. a copy of Ensign GroupAllergan’s Code of Conduct required by Section III.B.1;
56. the number of individuals Covered Persons required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals Covered Persons who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG OIG, upon request);
67. a) a copy of the letter (including all attachments) required by Section II.C.6 and III.B.2 sent to each party employing Third Party Personnel; b) a list of all such existing co-promotion and other applicable agreements; and c) a description of the entities’ response to Allergan’s letter;
8. a summary of all Policies and Procedures required by Section III.B III.B.3 (copies a copy of the such Policies and Procedures shall be made available to OIG upon request);
79. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;; and
b. the number of individuals Covered Persons required to be trained, percentage of individuals Covered Persons actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG OIG, upon request.
8. a description of the Disclosure Program required by Section III.E;
910. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; and (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group Allergan and the IRO; and (e) ;
11. a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupAllergan; 12. a description of the Disclosure Program required by Section III.E;
1013. a description of the process by which Ensign Group Allergan fulfills the requirements of Section III.F regarding Ineligible Persons;
1114. the name, title, and responsibilities of any person who is determined to be an Ineligible Person under Section III.F; the actions taken in response to the screening and removal obligations set forth in Section III.F;
15. a certification by the Chief Compliance Officer that the notice required by Section III.L was mailed to each HCP and HCI, the number of HCPs and HCIs that received a copy of the notice, a sample copy of the notice required by Section III.L, and a summary of the calls or messages received in response to the notice;
16. a list of all of Ensign GroupAllergan’s U.S. locations (including locations and mailing addresses); the corresponding name under which each location is doing business; and the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
1217. a description of Ensign GroupAllergan’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group LWCI shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. a copy of Ensign GroupLWCI’s Code of Conduct required by Section III.B.1;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions; and
c. with respect to active medical staff members, the number and percentage who completed the training, the type of training and the date received, and a description of LWCI’s efforts to encourage medical staff members to complete the training. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of the Disclosure Program required by Section III.E;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group LWCI and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupLWCI;
10. a description of the process by which Ensign Group LWCI fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign GroupLWCI’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group LWCI currently submits claims;
12. a description of Ensign GroupLWCI’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; andbusiness;and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 days after the Effective Date, Ensign Group WellCare shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:: Corporate Integrity Agreement WellCare Health Plans, Inc.
1. the name, address, phone number, and position description of the Chief Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer may have;
2. the names and positions of the members of the Corporate Compliance Committee, Compliance Liaisons, and Board Regulatory Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in Certifying Employees required by Section III.A.3III.A;
4. a copy of Ensign Group’s WellCare's Code of Conduct required by Section III.B.1III.▇.▇;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1III.▇.▇, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG OIG, upon request);
6. a summary of all Policies and Procedures required by Section III.B III.B.2 (copies a copy of the such Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;; and
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG OIG, upon request.
8. a description of the Disclosure Program required by Section III.E;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; and (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group WellCare and the IRO; and (e) Corporate Integrity Agreement WellCare Health Plans, Inc.
9. a certification from the IRO IRO(s) regarding its its/their professional independence and objectivity with respect to Ensign GroupWellCare;
10. a description of the Disclosure Program required by Section III.E;
11. a description of the process by which Ensign Group WellCare fulfills the requirements of Section III.F regarding Ineligible Persons;
1112. the name, title, and responsibilities of any person who is determined to be an Ineligible Person under Section III.F; the actions taken in response to the screening and removal obligations set forth in Section III.F; and the actions taken to identify, quantify, and repay any overpayments to Federal health care programs relating to items or services furnished, ordered or prescribed by an Ineligible Person;
13. a list of all of Ensign Group’s WellCare's locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s 's Medicare and state Medicaid program provider number and/or supplier number(s) (if applicable); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group WellCare currently submits claimsclaims (if applicable);
1214. a description of Ensign Group’s WellCare's corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
15. the certifications required by Section V.C.
Appears in 1 contract
Sources: Corporate Integrity Agreement (Wellcare Health Plans, Inc.)
Implementation Report. Within 150 days after the Effective Date, Ensign Group CHSI shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. The name, address, phone number, and position description of the Corporate Compliance and Privacy Officer required by Section III.A.1, and a summary of other noncompliance job responsibilities the Corporate Compliance and Privacy Officer may have;
2. the name, address, phone number, and position description of the each Senior Compliance Officer Director, Corporate Compliance Director, and Facility Compliance Officers required by Section III.AIII.A.2, and a summary of other noncompliance job responsibilities the each Senior Compliance Officer Director, Corporate Compliance Director, and Facility Compliance officers may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;have;
3. the names and positions of the members of the Corporate Compliance Work Group required by Section III.A.3;
4. the names and positions of the members of each Facility Compliance Committee required by Section III.A.4;
5. the names of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;III.A.5;
46. a copy of Ensign GroupCHSI’s Code of Conduct required by Section III.B.1;
57. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);request);
68. a summary of all Policies and Procedures required by Section III.B III.B.2 (copies of the Policies and Procedures shall be made available to OIG upon request);request);
79. the following information regarding each type of training required by Section III.C:III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. ; and
c. with respect to active medical staff members, the number and percentage who completed the training, the type of training and the date received, and a description of CHSI’s efforts to encourage medical staff members to complete the training. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
810. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1; 11. a description of the Disclosure Program required by Section III.EIII.F;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
10. a description of the process by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group SUN shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, business address, business phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of Ensign Groupthe written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;
(a) a copy of the letter (including all attachments) required by Sections II.C.8 and III.B.1 sent to each party employing Third Party Personnel; (b) a list of all existing co-promotion and other applicable agreements with the party employing the Third Party Personnel; and (c) a description of the entities’ responses to SUN’s Code letter;
6. a list of Conduct the Policies and Procedures required by Section III.B.1;
57. the number of individuals required to complete the Code of Conduct certification Training Plan required by Section III.B.1, the percentage of individuals who have completed such certification, III.C.1 and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of Board training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of the Disclosure Program risk assessment and internal review process required by Section III.E;III.D; SUN Corporate Integrity Agreement
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
SUN that includes a summary of all current and prior engagements between SUN and the IRO; 10. a description of the process Disclosure Program required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
III.F; 11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent the Ineligible Persons screening and sister companies, subsidiaries, and their respective lines of business; andremoval process required by Section III.G;
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group EGS shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. a copy of Ensign GroupEGS’s Code of Conduct required by Section III.B.1;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. ; A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.;
8. a description of the Risk Assessment and Mitigation Process required by Section III.E (if applicable);
9. a description of the Field Force Monitoring Program required by Section III.F; 10. a description of the Disclosure Program required by Section III.EIII.H;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
10. a description of the process by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 days after the Effective Date, Ensign Group Novartis shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Chief Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Chief Compliance Officer may have;
2. the names and positions of the members of the Country Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of Ensign Group’s Code of Conduct the written process to be followed by Certifying Employees in connection with completing the certification required by Section III.B.1III.A.4;
5. a copy of the number of individuals required to complete the Code of Conduct certification letter (including all attachments) required by Section III.B.1, Sections II.C.11 and III.B.1 sent to each party employing Third Party Personnel; a list of all existing co-promotion and other applicable agreements with the percentage party employing the Third Party Personnel; and a description of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available entities’ responses to OIG upon request)Novartis’ letter;
6. a summary list of all the Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request)III.B.2;
7. the following information regarding each type Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of the Disclosure Program risk assessment and internal review process required by Section III.EIII.D;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix Appendices A and B to this CIA; and (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
10Novartis that includes a summary of all current and prior engagements between Novartis and the IRO; 11. a description of the Ineligible Persons screening and removal process required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible PersonsIII.G;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 180 days after the Effective Date, Ensign Group Hill-Rom shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Chief Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. a copy of Ensign GroupHill-Rom’s Code of Conduct required by Section III.B.1;
54. the number of individuals Covered Persons required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals Covered Persons who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
65. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
76. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;
b. the number of individuals Covered Persons required to be trained, percentage of individuals Covered Persons actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of the Disclosure Program required by Section III.E;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group Hill-Rom and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupHill-Rom;
109. a description of the process by which Ensign Group Hill-Rom fulfills the requirements of Section III.F regarding Ineligible Persons;
1110. a list of all of Ensign GroupHill-Rom’s locations locations, other than those Hill-Rom’s Post Acute Care Division uses as warehouses or repair facilities (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group Hill-Rom currently submits claims;
1211. a description of Ensign GroupHill-Rom’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
12. the certifications required by Section V.C.
Appears in 1 contract
Sources: Corporate Integrity Agreement (Hill-Rom Holdings, Inc.)
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group SPD shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, business address, business phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the Risk Oversight Committee members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations requirements described in Section III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of Ensign Group’s Code of Conduct the written process for Certifying Employees to follow in order to complete the certification required by Section III.B.1III.A.4;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary list of all Policies and Procedures required by Section III.B (copies III.B;
6. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of Board training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessionsthe training, and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of (a) the Disclosure Program Focus Arrangements Tracking System required by Section III.EIII.D.1.a, (b) the internal review and approval process required by Section III.D.1.g; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
10. a description of the process by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group the DIG Entities shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors Directors’ compliance obligations described in Section III.A.3;
4. a copy of Ensign Group’s the DIG Entities’ Code of Conduct required by Section III.B.1;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be made available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;; and
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1; 9. a description of the Disclosure Program required by Section III.EIII.F;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
10. a description of the process by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 days after the Effective Date, Ensign Group IHS shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4;
5. a copy of Ensign GroupIHS’s Code of Conduct required by Section III.B.1;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B III.B.2 (copies of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type Training Plan for General and Arrangements Training required by Section III.C.1 and a description of the Board of Directors training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessionsIII.C.2;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of of: (a) the Disclosure Program Focus Arrangements Tracking System required by Section III.EIII.D.1.a; (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;
9. the following information regarding the Legal IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the Legal IRO has the qualifications outlined in Appendix A to this CIA; and (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the Legal IRO regarding its professional independence and objectivity with respect that it does not have a prohibited relationship to Ensign GroupIHS as set forth in Section III.E.4;
10. a description of the risk assessment and mitigation process required by which Ensign Group fulfills Section III.F; 11. a description of the requirements of Disclosure Program required by Section III.F III.G;
12. a certification that IHS has conducted the screening required by Section III.H regarding Ineligible Persons;
1113. a copy of IHS’s policies and procedures regarding the identification, quantification, and repayment of Overpayments required by Section III.J;
14. a list of all of Ensign GroupIHS’s locations subject to the CIA (including physical locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number number(s) and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group IHS currently submits claims;
1215. a description of Ensign GroupIHS’s corporate structure, including identification of any owners, parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group SpecialCare shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3. the names and positions position descriptions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in Certifying Employees required by Section III.A.3;
4. a copy of Ensign GroupSpecialCare’s Code of Conduct required by Section III.B.1;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be made available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B III.B.2 (copies of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;; and
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of: (a) the Focus Arrangements Tracking System required by Section III.D.1.a; (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1; 9. a description of the Disclosure Program required by Section III.EIII.F;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
10. a description of the process by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group Toccoa shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;III.A;
3. the names of the Executive Committee members who are responsible for satisfying the Executive Committee compliance obligations described in Section III.A.3;
4. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in Certifying Employees required by Section III.A.3;III.A.4;
45. a copy of Ensign GroupToccoa’s Code of Conduct required by Section III.B.1;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);III.B.1;
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);request);
7. the following information regarding each type Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training; and a schedule of when the training sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.was provided);
8. a description of the Disclosure Program required by Section III.E;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group Toccoa and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;Toccoa;
9. a description of the risk assessment and internal review process required by Section III.E;
10. a description of the process Disclosure Program required by which Ensign Group fulfills Section III.F;
11. a certification that Toccoa has implemented the screening requirements of described in Section III.F III.G regarding Ineligible Persons;, or a description of why Toccoa cannot provide such a certification;
1112. a copy of Toccoa’s policies and procedures regarding the identification, quantification and repayment of Overpayments required by Section III.I;
13. a list of all of Ensign GroupToccoa’s locations (including locations and mailing addresses); , the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; , each location’s Medicare and state Medicaid program provider number number(s) and/or supplier number(s); , and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group Toccoa currently submits claims;
1214. a description of Ensign GroupToccoa’s corporate structure, including identification of any individual owners, parent and sister companies, subsidiaries, and their respective lines of business; and
15. the certifications required by Section V.C.
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group PRMC shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in Physician Executives required by Section III.A.3III.A;
4. the name and position description of the Medical Director of the Cardiac Catheterization Laboratory required by Section III.A;
5. a copy of Ensign GroupPRMC’s Code of Conduct required by Section III.B.1;
56. a copy of all Policies and Procedures required by Section III.B.2;
7. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG OIG, upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
78. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions.
c. with respect to active medical staff members, the number and percentage who completed the training, the type of training and the date received, and a description of PRMC’s efforts to encourage medical staff members to complete the training. A copy of all training materials and the documentation supporting this information shall be made available to OIG OIG, upon request.
89. a description of the Disclosure Program required by Section III.EIII.F;
910. the following information regarding the IRO(s): ) and the Peer Review Consultant: (a) identityidentify, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
10. a description of the process by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group CHN shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4;
5. a copy of Ensign Groupthe written process for Certifying Employees required by Section III.A.4;
6. a copy of CHN’s Code of Conduct required by Section III.B.1;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
67. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
78. the following information regarding each type Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training; and a schedule of when the training sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of the Disclosure Program required by Section III.Ewas provided);
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group CHN and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupCHN;
10. a description of the risk assessment and internal review process required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
III.E; 11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; andthe Disclosure Program required by Section III.F;
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group Progenity shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, business address, business phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of Ensign Group’s Code of Conduct the written process for Certifying Employees to follow in order to complete the certification required by Section III.B.1III.A.4;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary list of all Policies and Procedures required by Section III.B (copies III.B;
6. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of Board training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessionsthe training, and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of (a) the Disclosure Program Focus Arrangements Tracking System required by Section III.EIII.D.1.a, (b) the internal review and approval process required by Section III.D.1.g; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
10. a description of the process by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 days after the Effective Date, Ensign Group Cephalon shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Chief Compliance Officer required by Section III.AIII.A. 1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3(a) a copy of the letter (including all attachments) required by Sections II.C.6 and III.B.2 sent to each party employing Third Party Personnel; (b) a list of all such existing agreements; and (c) a description of the entities’ response to Cephalon’s letter;
4. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in Certifying Employees required by Section III.A.3III.A.4;
45. a copy of Ensign GroupCephalon’s Code of Conduct required by Section III.B.1;
56. to the extent not already provided to the OIG, a copy of all Policies and Procedures required by Section III.B.3;
7. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG OIG, upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
78. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG OIG, upon request.;
89. a description of the Disclosure Program required by Section III.E;
910. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; and (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group Cephalon and the IRO; and (e) ;
11. a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupCephalon;
1012. a description of the process by which Ensign Group Cephalon fulfills the requirements of Section III.F regarding Ineligible Persons;
1113. the name, title, and responsibilities of any person who is determined to be an Ineligible Person under Section III.F; the actions taken in response to the screening and removal obligations set forth in Section III.F;
14. a list of all of Ensign GroupCephalon’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid Federal health care program provider number and/or or supplier number(s) (if applicable); , and the name and address of each Medicare and state Medicaid Federal health care program contractor to which Ensign Group Cephalon currently submits claimsclaims (if applicable);
1215. a description of Ensign GroupCephalon’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business;
16. a certification by the Chief Compliance Officer that the notice required by Section III.L was mailed to each health care provider and entity, the number of health care providers and entities that received a copy of the notice, a sample copy of the notice required by Section III.L, and a summary of the calls and messages received in response to the notice; and
17. the certifications required by Section V.C.
Appears in 1 contract
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group Cordant shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, business address, business phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of Ensign Group’s Code of Conduct the written process for Certifying Employees to follow in order to complete the certification required by Section III.B.1III.A.4;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary list of all Policies and Procedures required by Section III.B (copies III.B;
6. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of Board training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessionsthe training, and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of (a) the Disclosure Program Focus Arrangements Tracking System required by Section III.EIII.D.1.a, (b) the internal review and approval process required by Section III.D.1.g; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
10. a description of the process by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group Mylan shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described referenced in Section III.A.3;
4. a copy the names and positions of Ensign Group’s Code of Conduct the Certifying Employees required by Section III.B.1III.A.4;
5. a list of the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies III.B; 6. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of the Disclosure Program required by Section III.E;
97. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IROA; and (ed) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupMylan;
8. a description of the risk assessment and internal review process required by Section III.E; 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible PersonsIII.G;
11. a list of all of Ensign GroupMylan’s locations in the United States (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign GroupMylan’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group Lundbeck shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;III.A.2;
3. the names of the Board members who are responsible for satisfying the compliance obligations described in Section III.A.3;
4. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. a copy of Ensign Group’s Code of Conduct Certifying Employees required by Section III.B.1;III.A.4 and a written copy of the process to be followed by Certifying Employees in connection with completing the required certifications;
5. a list of the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies III.B.3;
6. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training and when the training was provided);
(a) a schedule of training sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of the letter (including all training materials attachments) required by Section III.C.4 sent to each party employing Third Party Personnel; (b) a list of all existing co-promotion and other applicable agreements with the documentation supporting this information shall be made available party employing the Third Party Personnel; and (c) description of the entities’ response to OIG upon request.Lundbeck’s letter;
8. a description of the Disclosure Program risk assessment and internal review process required by Section III.E;III.D;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IROA; and (ed) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;Lundbeck;
10. a description of the process Disclosure Program required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
III.F; 11. a list description of all of Ensign Group’s locations (including locations the Ineligible Persons screening and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
removal process required by Section III.G.; 12. a description of Ensign Group’s corporate structurethe Independent Charity PAP policies, including identification of any parent and sister companies, subsidiariesprocedures, and their respective lines of business; andpractices required by Section III.J;
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 180 days after the Effective Date, Ensign Group Mallinckrodt shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4 and a written copy of Ensign Group’s Code the process to be followed by Certifying Employees in connection with completing the required certifications;
5. a list of Conduct the Policies and Procedures required by Section III.B.1;
56. the number of individuals required to complete the Code of Conduct certification Training Plan required by Section III.B.1, the percentage of individuals who have completed such certification, III.C.1 and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of the Disclosure Program risk assessment and internal review process required by Section III.EIII.D;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
Mallinckrodt that includes a summary of all current and prior engagements between Mallinckrodt and the IRO; 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible PersonsIII.G.;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group Life Spine shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (“Implementation Report”). The Implementation Report shall, at a minimum, include:
1. the name, business address, business phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of Ensign Group’s Code of Conduct the written process for Certifying Employees to follow in order to complete the certification required by Section III.B.1III.A.4;
5. a list of the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies III.B.1 and a statement that indicates which activities Life Spine is not currently engaged in;
6. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of Board training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of the Disclosure Program risk assessment and internal review process required by Section III.EIII.D;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
Life Spine that includes a summary of all current and prior engagements between Life Spine and the IRO; 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by which Ensign Group fulfills Section III.G; 11. a description of the requirements of FFMP required by Section III.F regarding Ineligible PersonsIII.K;
1112. a description of the policies, procedures, and systems implemented pursuant to the Requirements Relating to Certain Non-Promotional Activites outlined in Section III.L; 13. a certification from the Compliance Officer that information regarding Payments has been posted on Life Spine’s website as required by Section III.N;
14. a list of all of Ensign GroupLife Spine’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; and the corresponding phone numbers and fax numbers; each location’s locations’ Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims) if any;
1215. a description of Ensign GroupLife Spine’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 days after the Effective Date, Ensign Group Aegerion shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described referenced in Section III.A.3;
4. a copy the names and positions of Ensign Group’s Code of Conduct the Certifying Employees required by Section III.B.1III.A.4 and a written copy of the process followed to complete the certification requirements set forth in Section III.A.4;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary list of all Policies and Procedures required by Section III.B (copies III.B;
6. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of the Disclosure Program RAMP required by Section III.EIII.D;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IROA; and (ed) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupAegerion;
9. a description of the Disclosure Program required by Section III.F;
10. a description of the Ineligible Persons screening and removal process required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible PersonsIII.G;
11. a certification by the Compliance Officer that the notice required by Section III.N was posted in the manner required by Section III.N and a summary of the calls or messages received in response to the notice;
12. a certification from the Compliance Officer that the information regarding Payments and the link to CMS’s Open Payments Data website has been posted on Aegerion’s website as required by Section III.O;
13. a list of all of Ensign GroupAegerion’s U.S-based locations (including locations and mailing addresses); the corresponding name under which each location is doing business; and the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s) (if applicable); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
1214. a description of Ensign Groupor a table depicting Aegerion’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
15. the certifications required by Section V.C.
Appears in 1 contract
Sources: Corporate Integrity Agreement (Novelion Therapeutics Inc.)
Implementation Report. Within 150 days after the Effective Date, Ensign Group Pfizer shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;III.A.2;
3. the names of the members of the RCC who are responsible for satisfying the compliance obligations described in Section III.A.3;
4. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. a copy of Ensign Group’s Code of Conduct Certifying Employees required by Section III.B.1;III.A.4;
5. a list of the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies III.B.3;
6. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of RCC training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics coveredcovered in the training for Covered Persons and for the RCC, the length of sessionseach type of training, and when the training was provided);
(a) a schedule of training sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of the letter (including all training materials attachments) required by Section III.C.4 sent to each party employing Third Party Personnel; (b) a list of all existing co-promotion and other applicable agreements with the documentation supporting this information shall be made available party employing the Third Party Personnel; and (c) a description of the entities' response to OIG upon request.Pfizer’s letter;
8. a description of the Disclosure Program Risk Assessment and Internal Review Process required by Section III.E;III.D;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IROA; and (ed) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
Pfizer; 10. a description of the process Disclosure Program required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
III.F; 11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent the Ineligible Persons screening and sister companies, subsidiaries, and their respective lines of business; andremoval process required by Section III.G;
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 days after the Effective Date, Ensign Group ICH shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4;
5. a copy of Ensign GroupICH’s Code of Conduct required by Section III.B.1;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessionsthe training, and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
8. a description of (a) the Disclosure Program Focus Arrangements Tracking System required by Section III.EIII.D.1.a, (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;
9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group ICH and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupICH;
10. a description of the risk assessment and internal review process required by which Ensign Group fulfills Section III.F; 11. a description of the requirements of Disclosure Program required by Section III.F III.G;
12. a certification that ICH has conducted the screening required by Section III.H regarding Ineligible Persons, or a description of why ICH cannot provide such a certification;
1113. a copy of ICH’s policies and procedures regarding the identification, quantification and repayment of Overpayments required by Section III.J;
14. a list of all of Ensign GroupICH’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number number(s) and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group ICH currently submits claims;
1215. a description of Ensign GroupICH’s corporate structure, including identification of any individual owners, parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 120 days after the Effective Date, Ensign Group Amerigroup shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Corporate Compliance Officer Officer, Plan Compliance Officers, and BRO required by Section III.A, and a summary of other noncompliance job responsibilities the Corporate Compliance Officer Officer, BRO, and Plan Compliance Officers may have;
2. the names and positions of the members of the Corporate Compliance Committee and Board Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. a copy of Ensign GroupAmerigroup’s Code of Conduct required by Section III.B.1;
4. a copy of all Policies and Procedures required by Section III.B.2;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG OIG, upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions;
; b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG OIG, upon request.
87. a description of the Disclosure Program required by Section III.E;
9III.E;8. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; and (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group Amerigroup and the IRO; and (e) ;
9. a certification from the IRO regarding its professional independence and objectivity with respect to Ensign GroupAmerigroup;
10. a description of the process by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Implementation Report. Within 150 days after the Effective Date, Ensign Group Jazz shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;
3. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. a copy of Ensign GroupJazz’s Code of Conduct required by Section III.B.1;
4. a copy of all Policies and Procedures required by Section III.B.2;
5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG OIG, upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type of training required by Section III.C:
a. a description of such training, including a summary of the topics covered, the length of sessions, sessions and a schedule of training sessions;
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG OIG, upon request.
8. Corporate Integrity Agreement Jazz Pharmaceuticals, Inc. 7. a description of the Disclosure Program required by Section III.E;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; and (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group Jazz and the IRO; and (e) the proposed start and completion dates of each Review;
9. a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
Jazz; 10. a description of the process by which Ensign Group Jazz fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and
Appears in 1 contract
Sources: Corporate Integrity Agreement (Jazz Pharmaceuticals Inc)
Implementation Report. Within 150 days after the Effective Date, Ensign Group Merit shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, business address, business phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2. the names and positions of the members of the Compliance Committee required by Section III.AIII.A.2;
3. the names and positions of the Audit Committee members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of Ensign Group’s Code the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;
5. a list of Conduct the Policies and Procedures required by Section III.B.1;
56. the number of individuals required to complete the Code of Conduct certification Training Plan required by Section III.B.1, the percentage of individuals who have completed such certification, III.C.1 and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training and a schedule of when the training sessionswas provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of the Disclosure Program risk assessment and internal review process required by Section III.EIII.D;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
Merit that includes a summary of all current and prior engagements between Merit and the IRO; 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible PersonsIII.G;
11. a list description of all of Ensign Group’s locations (including locations policies, procedures, and mailing addresses)systems implemented pursuant to the Requirements Relating to Certain Promotional Activities outlined in Section III.K; the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; andthe FFMP required by Section III.L;
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 days after the Effective Date, Ensign Group USWM shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, address, phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;have; Corporate Integrity Agreement – USWM
2. the names and positions of the members of the Compliance Committee required by Section III.A;III.A.2;
3. the names and positions of the members of the Board of Directors members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;III.A.3;
4. a copy the names and positions of Ensign Group’s Code of Conduct the Certifying Employees required by Section III.B.1;III.A.4;
5. a list of the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies III.B.3;
6. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training and a schedule of when the training sessions;was provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of the Disclosure Program risk assessment and internal review process required by Section III.E;III.D;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;USWM;
9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; andIII.G;
Appears in 1 contract
Sources: Corporate Integrity Agreement
Implementation Report. Within 150 days after the Effective Date, Ensign Group Essilor shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1. the name, business address, business phone number, and position description of the Compliance Officer required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have;have;
2. the names and positions of the members of the Compliance Committee required by Section III.A;III.A.2;
3. the names of the Board members who are responsible for satisfying the Board compliance requirements described in Section III.A.3;
4. the names and positions of the members of the Board of Directors who are responsible for satisfying the Board of Directors compliance obligations described in Certifying Employees required by Section III.A.3;
4. III.A.4 and a copy of Ensign Group’s Code the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;
5. a list of Conduct the Policies and Procedures required by Section III.B.1;
56. the number of individuals required to complete the Code of Conduct certification Training Plan required by Section III.B.1, the percentage of individuals who have completed such certification, III.C.1 and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request);
6. a summary of all Policies and Procedures required by Section III.B (copies description of the Policies and Procedures shall be made available to OIG upon request);
7. the following information regarding each type Board of Directors training required by Section III.C:
a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training and a schedule of when the training sessions;was provided);
b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.
87. a description of the Disclosure Program risk assessment and internal review process required by Section III.E;III.D;
98. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a summary and description of any and all current and prior engagements and agreements between Ensign Group and the IRO; and (e) a certification from the IRO regarding its professional independence and objectivity with respect to Ensign Group;
Essilor that includes a summary of all current and prior engagements between Essilor and the IRO; 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by which Ensign Group fulfills the requirements of Section III.F regarding Ineligible Persons;
11. a list of all of Ensign Group’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which Ensign Group currently submits claims;
12. a description of Ensign Group’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; andIII.G;
Appears in 1 contract
Sources: Corporate Integrity Agreement